I've watched plenty of companies chase a hot trend and spend their way into trouble. The story usually looks thrilling on the ...

It’s well known that the difference in executable size between a compiled binary and one hand-written in optimized assembler ...

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...

The memory chipmaker is going on a historic stock market run.

The final months of the fashion tech start-up CaaStle included fake audits, stock buybacks and a damage control strategy led ...

Rose Chapman walks with purpose, but not without fear. A quiet hero in video game developer Quantic Dream's Detroit: Become Human, from 2018, Rose is a farmer, a mother, and a woman who helps ...

Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss ...

Adobe is approaching a crucial earnings report as growth ambitions, strategic shifts, and investor expectations converge ...

Automatic Data Processing improved its revenue from $11.7B in FY 2016 to $20.6B in FY 2025. That’s a CAGR of 6.5%. See why I ...

Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting ...

Relying on recruitment isn't enough in 2026. Learn how to protect your fleet's uptime by addressing the skills gap and ...